Prediction of Radiosensitivity of Acetylated Cell Through FTIR Spectroscopy

ZHANG Fengqiu; HUANG Qing

doi:10.11804/NuclPhysRev.34.04.790

Histone acetylation is one of important epigenetic modifications, and histone in most of tumor cells shows low acetylation state. However, histone deacetylase inhibitor (HDACi) can correct abnormal acetylation status, induce cell cycle arrest and apoptosis. Trichostatin A (TSA) is one of the representatives of histone deacetylase inhibitors, which can inhibit histone deacetylase, increase the acetylation level of histone and nonhistone in cell. Fourier transform infrared (FTIR) spectroscopy is a powerful analytical tool which can detect nondestructively, quatitatively and quantitatively biological samples without bio-tagging and bio-labeling. FTIR spectroscopy technology has multiple advantages, including finger-print characteristics, rapid analysis, high resolution and good repeatability. Therefore, it has been widely used in the research of biological processes. This work applied FTIR spectroscopy to study the changes in cells treated with TSA, compared the acetylation level according to FTIR intensity ratio of methyl to methylene stretching vibration, and based on the FTIR analysis predicted the radiosensitivity of the cells with different acetylation levels. As a result, we have verified that the damage caused by radiation in acetylated cells can be evaluated by the ratio of methyl and methylene intensity which is positively correlated with cellular radiosensitivity. Therefore, this work demonstrates that FTIR spectroscopy can be useful for the prediction of radiosensitivity and may also open a door for the study of relationship between epigenetics and radiation bio-effects.

Prediction of Radiosensitivity of Acetylated Cell Through FTIR Spectroscopy

1. School of Nuclear Science and Technology, University of Science and Technology of China, Hefei 230026, China;

2. Institute of Technical Biology and Agriculture Engineering, Hefei Institutes of Physical Science, Chinese Academy of Sciences, Hefei 230031, China;

3. School of Physical Engineering, Zhengzhou University, Zhengzhou 450001, China

Funds: National Natural Science Foundation of China (11475217, 11635013);Strategic Priority Research Program of Chinese Academy of Sciences (XDA08040107)

Received Date: 2016-11-02

Rev Recd Date: 2016-11-11

Publish Date: 2017-12-20

Key words:

Abstract: Histone acetylation is one of important epigenetic modifications, and histone in most of tumor cells shows low acetylation state. However, histone deacetylase inhibitor (HDACi) can correct abnormal acetylation status, induce cell cycle arrest and apoptosis. Trichostatin A (TSA) is one of the representatives of histone deacetylase inhibitors, which can inhibit histone deacetylase, increase the acetylation level of histone and nonhistone in cell. Fourier transform infrared (FTIR) spectroscopy is a powerful analytical tool which can detect nondestructively, quatitatively and quantitatively biological samples without bio-tagging and bio-labeling. FTIR spectroscopy technology has multiple advantages, including finger-print characteristics, rapid analysis, high resolution and good repeatability. Therefore, it has been widely used in the research of biological processes. This work applied FTIR spectroscopy to study the changes in cells treated with TSA, compared the acetylation level according to FTIR intensity ratio of methyl to methylene stretching vibration, and based on the FTIR analysis predicted the radiosensitivity of the cells with different acetylation levels. As a result, we have verified that the damage caused by radiation in acetylated cells can be evaluated by the ratio of methyl and methylene intensity which is positively correlated with cellular radiosensitivity. Therefore, this work demonstrates that FTIR spectroscopy can be useful for the prediction of radiosensitivity and may also open a door for the study of relationship between epigenetics and radiation bio-effects.

HTML

Reference (31)

[1]	WASON M S, COLON J, DAS S, et al. Nanomedicine Nanotechnology Biology & Medicine, 2013, 9(4):558.
[2]	LAWRENCE Y R, Li X A, EI N I, et al. International Journal of Radiation Oncology Biology Physics, 2010, 76(Suppl 3):S20.
[3]	SHA K, WINN L M. Birth Defects Research Part B Developmental & Reproductive Toxicology, 2010, 89(2):124.
[4]	ENTIN-MEER M, REPHAELI A, YANG X, et al. Molecular cancer therapeutics, 2005, 4(12):1952.
[5]	MUNSHI A, KURLAND J F, NISHIKAWA T, et al. Clinical Cancer Research, 2005, 11(13):4912.
[6]	JUNG M, VELENA A, CHEN B, et al. Radiation Research, 2005, 163(5):488.
[7]	ZHANG Y, JUNG M, DRITSCHILO A, et al. Radiation Research, 2004, 161(6):667.
[8]	VIGUSHIN D M, ALI S, PACE P E, et al. Clinical Cancer Research, 2001, 7(4):971.
[9]	YOSHIDA M, HOSHIKAWA Y, KOSEKI K, et al. Journal of Antibiotics, 1990, 43(9):1101.
[10]	WHARTON W, SAVELL J, CRESS W D, et al. Journal of Biological Chemistry, 2000, 275(43):33981.
[11]	KIM J H, KIM I H, SHIN J H, et al. Cancer Research and Treatment:Official Journal of Korean Cancer Association, 2013, 45(4):334.
[12]	ZHANG F, ZHANG T, TENG Z H, et al. Cancer biology & therapy, 2009, 8(9):823.
[13]	HSIAO K Y, MIZZEN C A. Journal of Molecular Cell Biology, 2013, 5(3):157.
[14]	ZILBERMAN Y, BALLESTREM C, CARRAMUSA L, et al. Journal of Cell Science, 2009, 122(19):3531.
[15]	MATSUYAMA A, SHIMAZU T, SUMIDA Y, et al. EMBO journal, 2002, 21(24):6820.
[16]	GASPER R, MIJATOVIC T, BÉNARD A, et al. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease, 2010, 1802(11):1087.
[17]	ZHANG F, HUANG Q, YAN J, et al. Analytical chemistry, 2015, 87(4):2511.
[18]	HILL I R, LEVIN I W. Journal of Chemical Physics, 1979, 70(2):842.
[19]	MICHAELIAN K H, ZHANG S L, HALL R H, et al. Canadian Journal of Analytical Sciences & Spectroscopy, 2001, 46(1):10.
[20]	XIA Shouxuan. Radiobiology[M]. Beijing:Military Medical Science Press, 1998:243. (in Chinese) (夏寿萱. 放射生物学[M]. 北京:军事医学科学出版社, 1998:243.)
[21]	WARTERS R L, NEWTON G L, OLIVE P L, et al. Radiation Research, 1999, 151:354.
[22]	DOUKI T, BRETONNIERE Y, CADET J. Radiation Research, 2000, 153(1):29.
[23]	TAKATA H, HANAFUSA T, MORI T, et al. PloS one, 2013, 8(10):e75622.
[24]	STRAHL B D, ALLIS C D. Nature, 2000, 403(6765):41.
[25]	GREGORY P D, WAGNER K, HÖRZ W. Experimental Cell Research, 2001, 265(2):195.
[26]	SHUBASSI G, ROBERT T, VANOLI F, et al. Cancer Research, 2012, 72(6):1332.
[27]	CHAUHAN D, TIAN Z, ZHOU B, et al. Clinical Cancer Research, 2011, 17(16):5311.
[28]	CHINNAIYAN P, VALLABHANENI G, ARMSTRONG E, et al. International Journal of Radiation Oncology Biology Physics, 2005, 62(1):223.
[29]	SHOJI M, NINOMIYA I, MAKINO I, et al. International Journal of Oncology, 2012, 40(6):2140.
[30]	SOUTOGLOU E, DORN J F, SENGUPTA K, et al. Nature Cell Biology, 2007, 9(6):675.
[31]	MILLER K M, TJEERTES J V, COATES J, et al. Nat Struct Mol Biol, 2010, 17(9):1144.

Prediction of Radiosensitivity of Acetylated Cell Through FTIR Spectroscopy

doi: 10.11804/NuclPhysRev.34.04.790

Abstract

References

Proportional views

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views